Herriot Tabuteau

2021

In 2021, Herriot Tabuteau earned a total compensation of $8.1M as Chief Executive Officer, President and Chairman of the Board at Axsome Therapeutics, a 10% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$349,350
Option Awards$4,666,355
Salary$685,000
Stock Awards$2,333,251
Other$20,675
Total$8,054,631

Tabuteau received $4.7M in option awards, accounting for 58% of the total pay in 2021.

Tabuteau also received $349.4K in non-equity incentive plan, $685K in salary, $2.3M in stock awards and $20.7K in other compensation.

Rankings

In 2021, Herriot Tabuteau's compensation ranked 1,441st out of 12,412 executives tracked by ExecPay. In other words, Tabuteau earned more than 88.4% of executives.

ClassificationRankingPercentile
All
1,441
out of 12,412
88th
Division
Manufacturing
519
out of 5,498
91st
Major group
Chemicals And Allied Products
192
out of 2,374
92nd
Industry group
Drugs
159
out of 2,095
92nd
Industry
Pharmaceutical Preparations
108
out of 1,542
93rd

Pay ratio

Herriot Tabuteau's Pay$8,054,631
Median Employee's Pay$690,964
Pay Ratio

12

to 1

In 2021, the annual total compensation of Herriot Tabuteau was $8,054,631.

The annual total compensation of the median employee at Axsome Therapeutics was $690,964.

The ratio of Herriot Tabuteau's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 22, 2022.

Tabuteau's colleagues

We found two more compensation records of executives who worked with Herriot Tabuteau at Axsome Therapeutics in 2021.

2021

Mark MA

Axsome Therapeutics

Chief Operating Officer

2021

Nick Pizzie

Axsome Therapeutics

Chief Financial Officer

News

In-depth

You may also like